Gene · 325
Papers4,193
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,193
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human adaptation to high altitude: a review of convergence between genomic and proteomic signatures. | Hum Genomics | 2022 | 35841113 | PubTator, text mining | PubMed |
| Research progress on serological indices and their clinical application in rheumatoid arthritis. | J Clin Lab Anal | 2022 | 35838016 | PubTator, text mining | PubMed |
| Evaluation of Transcriptomic Responses in Livers of Mice Exposed to the Short-Chain PFAS Compound HFPO-DA. | Front Toxicol | 2022 | 35832492 | PubTator, text mining | PubMed |
| Inflammatory response to the ischaemia-reperfusion insult in the liver after major tissue trauma. | Eur J Trauma Emerg Surg | 2022 | 35831749 | PubTator, text mining | PubMed |
| PTX3 in Granuloma Formation and Sarcoidosis: Helping Macrophages Accept a "Complement". | Am J Respir Crit Care Med | 2022 | 35820078 | PubTator, text mining | PubMed |
| Cryo-EM structures of prion protein filaments from Gerstmann-Sträussler-Scheinker disease. | Acta Neuropathol | 2022 | 35819518 | PubTator, text mining | PubMed |
| Bleeding Propensity in Waldenström Macroglobulinemia: Potential Causes and Evaluation. | Thromb Haemost | 2022 | 35817084 | PubTator, text mining | PubMed |
| An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study. | Orphanet J Rare Dis | 2022 | 35810311 | PubTator, text mining | PubMed |
| Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF). | Cells | 2022 | 35805179 | PubTator, text mining | PubMed |
| Amyloid fil rouge from invertebrate up to human ageing: A focus on Alzheimer disease. | Mech Ageing Dev | 2022 | 35798289 | PubTator, text mining | PubMed |
| Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients. | PLoS One | 2022 | 35797333 | PubTator, text mining | PubMed |
| Determination of deleterious single-nucleotide polymorphisms of human LYZ C gene: an in silico study. | J Genet Eng Biotechnol | 2022 | 35776277 | PubTator, text mining | PubMed |
| Major Molecular Factors Related to Leishmania Pathogenicity. | Front Immunol | 2022 | 35769465 | PubTator, text mining | PubMed |
| Pentraxin 3 Inhibits Complement-driven Macrophage Activation to Restrain Granuloma Formation in Sarcoidosis. | Am J Respir Crit Care Med | 2022 | 35767663 | PubTator, text mining | PubMed |
| Serum Proteomic Analysis Identifies SAA1, FGA, SAP, and CETP as New Biomarkers for Eosinophilic Granulomatosis With Polyangiitis. | Front Immunol | 2022 | 35757752 | PubTator, text mining | PubMed |
| Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts? | Biomedicines | 2022 | 35740444 | PubTator, text mining | PubMed |
| Pentraxin 3 regulated by miR-224-5p modulates macrophage reprogramming and exacerbates osteoarthritis associated synovitis by targeting CD32. | Cell Death Dis | 2022 | 35739102 | PubTator, text mining | PubMed |
| Enhanced Transmissibility and Decreased Virulence of HIV-1 CRF07_BC May Explain Its Rapid Expansion in China. | Microbiol Spectr | 2022 | 35727067 | PubTator, text mining | PubMed |
| Identification of a distal enhancer that determines the expression pattern of acute phase marker C-reactive protein. | J Biol Chem | 2022 | 35724961 | PubTator, text mining | PubMed |
| Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis. | Front Pharmacol | 2022 | 35721111 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/325/papers?page=20